Antibody-directed enzyme prodrug therapy (ADEPT) for treatment of major solid tumour disease

被引：16

作者：

Blakey, DC

Burke, PJ

Davies, DH

Dowell, RI

Melton, RG

Springer, CJ

Wright, AF

机构：

[1] CHARING CROSS HOSP,DEPT MED ONCOL,LONDON W6 8RF,ENGLAND

[2] PUBL HLTH LAB SERV,CTR APPL MICROBIOL & RES,SALISBURY,WILTS,ENGLAND

[3] ICR,CRC,CTR CANC THERAPEUT,SUTTON,SURREY,ENGLAND

来源：

关键词：

D O I：

10.1042/bst0231047

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：1047 / 1050

页数：4

共 21 条

[1] Bagshawe K D, 1993, Adv Pharmacol, V24, P99, DOI 10.1016/S1054-3589(08)60935-7
[2] A CYTO-TOXIC AGENT CAN BE GENERATED SELECTIVELY AT CANCER SITES
BAGSHAWE, KD
SPRINGER, CJ
SEARLE, F
ANTONIW, P
SHARMA, SK
MELTON, RG
SHERWOOD, RF
[J]. BRITISH JOURNAL OF CANCER, 1988, 58 (06) : 700 - 703
[3] BAGSHAWE KD, 1995, TUMOUR TARGETING, V1, P1
[4] Blakey D. C., 1994, Proceedings of the American Association for Cancer Research Annual Meeting, V35, P507
[5] Blakey D C, 1993, Cell Biophys, V22, P1
[6] BLAKEY DC, 1995, BR J CANCER S24, V71, P12
[7] BLAKEY DC, 1994, BR J CANCER S21, V69, P14
[8] BOSSLET K, 1994, CANCER RES, V54, P2151
[9] 2ND GENERATION ANALOGS OF ETOPOSIDE AND MITOMYCIN-C
DOYLE, TW
VYAS, DM
[J]. CANCER TREATMENT REVIEWS, 1990, 17 (2-3) : 127 - 131
[10] ANTIBODY-DIRECTED ENZYME PRODRUG THERAPY - POTENTIAL IN CANCER
KNOX, RJ
CONNORS, TA
[J]. CLINICAL IMMUNOTHERAPEUTICS, 1995, 3 (02): : 136 - 153